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Objectives: The mechanisms of cardiac allograft vasculopathy and its predisposing
factors are multifactorial and as yet not well established. To determine the influence
of endothelial dysfunction on the development of intimal thickening, we prospec-
tively analyzed the vasomotor response to acetylcholine and nitroglycerin, as well
as other donor and recipient variables. Findings were correlated with the coronary
intimal thickness, which was evaluated by means of intravascular ultrasonography.
Methods: Nineteen patients who had undergone heart transplantation 4.89 ± 2.35
years previously and who had angiographically normal coronary arteries were
included. Endothelial function was analyzed by quantitative coronary analysis of
the vasomotor response of the left anterior descending artery to acetylcholine. An
intimal thickness index, reflecting the percentage of intima obstructing the coronary
lumen, was calculated.
Results: Nine (47%) patients showed endothelial dysfunction, and the remaining 10
(53%) patients had a normal response. Four (44%) of 9 patients with a weight gain
of greater than 20% after the operation showed endothelial dysfunction compared
with none of the 10 patients with normal responses (P < .04). The severity of the inti-
mal thickness correlated with the years after transplant (r = 0.45, P < .05). Patients
with endothelial dysfunction had more intimal thickening than those without (32%
± 17% vs 17% ± 12%, respectively; P < .05). Furthermore, the degree of intimal
thickening correlated with the magnitude of the vasomotor response to acetylcholine
(r = –0.60, P = .006). No relationship was found between intimal thickness and the
vasodilatory response to nitroglycerin. As independent variables for intimal thick-
ness, multivariate analysis detected the magnitude of the response to acetylcholine
(P = .0005), years after transplant (P = .01), and ischemic time (P = .03).
Conclusions: Cardiac allograft vasculopathy is a multifactorial disease the severity
of which increases over time. Endothelial dysfunction is a predictive factor of inti-
mal thickening severity. Predisposing factors that provoke endothelial injury, such
as perioperative ischemic time and obesity, may contribute to the development of
allograft vasculopathy.
Cardiac allograft vasculopathy is the main cause of morbidity and mor-tality after the first year of heart transplantation.1-3 Diagnosis on thebasis of coronary angiography is limited to detect minimal or diffuseintimal thickening. Previous studies have demonstrated that intravas-cular ultrasonography (IVUS) is a sensitive technique for accuratedetection of intimal thickening.4 The pathogenesis of allograft vascu-
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lopathy is not clearly elucidated, although it has been consid-
ered that early immunologic and nonimmunologic damage of
the endothelium may initiate this process.5-8 Normal coro-
nary arteries with intact endothelium vasodilate in response
to arterial dilator agonists, such as acetylcholine, by stimulat-
ing the release of endothelium-derived relaxing factors, iden-
tified as nitric oxide.9 In patients with coronary artery disease
and allograft vasculopathy, a paradoxical vasoconstrictor
response to acetylcholine is commonly observed, indicating
endothelial dysfunction.10-12 Whether the presence of
endothelial dysfunction could predispose to the development
of intimal thickening is controversial.13-20 To test the hypoth-
esis that endothelial dysfunction is related to the degree of
intimal thickening, we prospectively analyzed the vasomotor
response to acetylcholine (vasodilator endothelium depen-
dent) and nitroglycerin (vasodilator endothelium indepen-
dent), as well as other donor and recipient variables. Findings
were correlated with the intimal thickness, which was evalu-
ated with IVUS.
Methods
Patients
Nineteen patients (15 men and 4 women; mean age, 52 ± 11 years;
age range, 28-68 years) who had undergone orthotopic heart trans-
plantation 1 or more years before the study (mean, 4.89 ± 2.35
years; range, 1-9 years) and who had angiographically normal
coronary arteries and negative exercise thallium-201 perfusion
scan results were included in the present study.
The study coincided with the routine annual angiographic
examination; a clinical, echocardiographic, hemodynamic, and
scintigraphic evaluation was undertaken. All patients had normal
left ventricular size and ejection fraction, as well as cardiac index
and end-diastolic left ventricular filling pressures. Concomitantly
with the angiographic exploration, endothelial function and IVUS
studies were performed. Recipient clinical variables included age,
sex, diagnosis before heart transplantation, arterial blood pressure,
obesity (weight gain after transplantation >20%), diabetes melli-
tus, plasma triglyceride and total cholesterol levels, number of
treated biopsy-verified episodes of acute rejection during the first
year, history of cytomegalovirus infection, and interval elapsed
after heart transplantation. Donor variables were age, sex, and cold
ischemia time (Table 1). 
Study Protocol of Endothelial Dysfunction
Vasodilator drugs were discontinued at least 18 hours before car-
diac catheterization. After completion of diagnostic catheteriza-
tion, 5000 U of sodium heparin was administered, and an 8F
Judkins catheter was positioned in the left coronary artery ostium.
An angioplasty guide wire (0.014 inch) was advanced to the distal
segment of the left anterior descending (LAD) coronary artery,
and a 3F infusion catheter was placed 0.5 to 1 cm distal to the ori-
gin of the first diagonal branch. The guide wire was removed. A
series of sequential 3-minute intracoronary perfusions of 5% dex-
trose and graded concentrations of acetylcholine (10–6, 10–5, and
10–4 mol/L) and nitroglycerin (40 µg/mL) were then administered
with a perfusion pump at a constant flow rate of 0.80 mL/min. A
coronary angiogram was performed at the end of each perfusion.
The presence of a normal vasomotor response was identified as an
TABLE 1. Recipient and donor characteristics
Overall Normal vasomotor response Endothelial dysfunction
(n = 19) (n = 10) (n = 9) P value
Recipient variables
Age (y) 52 ± 11 49 ± 10 53 ± 11 NS
Male/female ratio 15/4 7/3 8/1 NS
Diagnosis before heart transplant
Dilated cardiomyopathy 15 (79%) 9 (90%) 6 (67%)
Ischemic cardiomyopathy 3 (16%) 0 (0%) 3 (33%)
Valvular heart disease 1 (5%) 1 (10%) 0 (0%) NS
Mean blood pressure (mm Hg) 109 ± 11 109 ± 11 110 ± 6 NS
Smoking 1 (5%) 0 (0%) 1 (11%) NS
Triglycerides (mmol/L) 1.79 ± 0.60 1.56 ± 0.47 2.04 ± 0.64 NS
Cholesterol (mmol/L) 6.19 ± 0.98 6.23 ± 0.98 6.16 ± 0.76 NS
Diabetes mellitus 1 (5%) 1 (10%) 0 (0%) NS
Obesity 4 (21%) 0 (0%) 4 (44%) .04
No. of treated rejection episodes 5.9 ± 3.3 6.50 ± 3.98 5.22 ± 2.49 NS
Cytomegalovirus infection 4 (21%) 3 (30%) 1 (11%) NS
Time after heart transplant (y) 4.89 ± 2.35 5.40 ± 2.80 4.33 ± 1.73 NS
Donor data
Donor age (y) 26 ± 10 25 ± 9 35 ± 14 NS
Male/female ratio 9/10 4/6 5/4 NS
Ischemic time (min) 140 ± 44 134 ± 37 148 ± 53 NS
NS, Not significant.
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increase in the coronary luminal diameter after perfusion of
acetylcholine. Endothelial dysfunction was deemed to be present
when a decrease in the coronary luminal diameter was detected.
Quantitative Coronary Angiography
Quantitative analysis of the coronary artery diameter was per-
formed with a computer-assisted, automated, edge-contour detec-
tion system (Integris HM3000, Phillips Medical System, Leiden,
The Netherlands) in the view that best allowed visualization of the
LAD artery. After calibration of the arterial diameter with the
Judkins catheter for reference, changes in the luminal diameter in
response to vasoactive substances were evaluated. Measurements
were performed on a 3- to 5-cm–long LAD segment approximately
2 cm distal to the tip of the perfusion catheter in an end-diastolic
frame identified by a simultaneously recorded electrocardiogram.
IVUS Imaging
Nitroglycerin (2 mg) was administered in the LAD artery after
removal of the perfusion system and before IVUS. The imaging
system comprised a 30-MHz transducer enclosed within an
acoustic housing on the tip of a 3.2F catheter (CVIS Inc,
Sunnyvale, Calif). The intracoronary imaging system was passed
into the distal segment of the LAD artery over the 0.014-inch guide
wire. The pullback was initiated 4 to 6 cm distal from the origin of
the first diagonal branch. The cross-sectional image with the high-
est intimal thickening was selected for measurement. Ultrasound
images were recorded on videotape for further analysis. 
The area of intimal thickening was calculated by planimetry,
subtracting the cross-sectional area of the adventitial aspect of the
intima from the cross-sectional area of the lumen. The result, the
area of intimal thickening, was divided by the cross-sectional area
of the adventitial aspect of the intima to obtain an intimal thick-
ness index.15 This ratio was multiplied by 100 to reflect the per-
centage of the luminal obstruction caused by the intimal thickness.
Immunosuppression and Diagnosis of Allograft
Rejection in Early and Late Stages of Follow-up
All patients were managed with a standard 3-drug immunosup-
pressive regimen, including cyclosporine (INN: ciclosporin), aza-
thioprine, and prednisone. The diagnosis of cardiac allograft
rejection was made by means of histologic interpretation of
endomyocardial biopsy specimens obtained during the first year of
heart transplantation. The frequency of biopsies was one for the
first 4 weeks, every 15 days until the third month, monthly from
the third month to the sixth month, and then once each at 9 and
12 months. Classification of rejection was based on the recom-
mendations of the International Society of Heart and Lung
Transplantation.21 Decision to treat for acute rejection during the
first year of transplantation was based on the detection of myocyte
damage at biopsy. Treatment for rejection included a 3-day course
of bolus of steroids plus antithymocytic globulin, followed by a
control biopsy within 4 to 5 days after treatment. In this series an
angiogram and thallium scintigraphy were performed annually.
Statistical Analysis
Changes in coronary diameter after acetylcholine or nitroglycerin
infusions were expressed as a percentage of the luminal diameter
during 5% dextrose infusion. Unpaired t tests and Fisher exact
tests were used to assess differences between continuous and cat-
egorical variables. A correlation analysis was performed between
the intimal thickening and other continuous variables of the donor
and recipient. Multiple regression analysis with the stepwise pro-
cedure was used to identify independent variables related to the
degree of intimal thickness. All data are expressed as means ± SE.
Results
Endothelium-dependent and Endothelium-independent
Vasoreactivity of Coronary Arteries
During the perfusion of acetylcholine, 9 (47%) patients had
endothelial dysfunction, and the remaining 10 (53%)
patients had a normal vasomotor response. The decrease in
coronary diameter in patients with endothelial dysfunction
was –23% ± 19% compared with the control infusion
(Figure 1). The increase in the coronary diameter with a
normal vasomotor response was 17% ± 11% (P < .005).
After infusion of the endothelium-independent vasodilator
nitroglycerin, patients with and without endothelial dys-
function reached a maximum vasodilatation of 10% ± 9%
and 23% ± 20%, respectively (not significant). Four (44%)
of 9 overweight patients had endothelial dysfunction com-
pared with none of 10 patients with normal endothelial
function (P < .04). We did not find statistical differences in
the remaining donor and receipt variables for the 2 groups
of patients with and without endothelial dysfunction (Table
1). In addition, there was no relation between the nitroglyc-
erin vasomotor response and any of the variables studied.
Intimal Thickening and Receipt and Donor Variables
In spite of the normal angiographic appearance of the coro-
nary arteries, all patients demonstrated variable degrees of
Figure 1. Plot of sequential changes in the coronary diameter after
infusions of 5% dextrose (basal), graded acetylcholine (Ach), and
nitroglycerin (NTG) in the distal LAD artery. Two patterns of vaso-
motor responses to acetylcholine were observed: a normal vaso-
motor response and a paradoxical vasoconstrictor response.
*Statistical differences between patients with and without
endothelial dysfunction.
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intimal thickening by IVUS (mean, 24% ± 16%; range, 5%-
61%). There was a correlation between the severity of the
intimal thickness and the years after transplant (r = 0.45, P
< .05; Figure 2). In 11 patients with an intimal thickening of
less than 25%, time from heart transplant was 4.0 ± 2.2
years. However, in 8 patients with an intimal thickening of
25% or greater, the time elapsed after operation was 6.1 ±
2.0 years (P < .05). We found no correlation between the
degree of intimal thickness and the other recipient and
donor characteristics analyzed.
Intimal Thickening and Vasomotor Response to
Acetylcholine and Nitroglycerin
The group with endothelial dysfunction showed a greater
intimal thickness index compared with those with a normal
vasomotor response (32% ± 17% vs 17% ± 12%, P < .05;
Figure 3). In addition, there was an inverse correlation
between the intimal thickening and the magnitude of the
coronary vasomotor response to acetylcholine (r = –0.60, P
= .006; Figure 4). No relationship was found between the
degree of intimal thickness and the vasodilatory coronary
response to nitroglycerin. Multiple regression analysis
detected as independent variables related to the degree of
intimal thickness and the magnitude of the vasomotor
response to acetylcholine (P = .0005), as well as time
elapsed after heart transplant (P = .01) and ischemic time (P
= .03, Table 2).
Discussion
The most acceptable mechanism of cardiac allograft vascu-
lopathy is an immunologic mediated endothelial injury.6,7
Morphologic studies suggest that the functional and struc-
tural abnormalities of the endothelium precede the develop-
ment of the atherosclerotic process.22,23 However, in the
human patient neither angiography nor IVUS shows a clear
relationship between the existence of an abnormal endothe-
lial function and development of allograft vascular dis-
ease.11-20 In the present study we found that patients with
endothelial dysfunction had a higher degree of intimal
thickness than those without. Moreover, the magnitude of
Figure 2. Scatterplot between the time elapsed after heart trans-
plantation and intimal thickening evaluated by IVUS (r = 0.45,
P < .05).
Figure 3. Box plot showing more intimal thickening in heart trans-
plant recipients with endothelial dysfunction than in those with a
normal endothelial function (P < .05).
Figure 4. Scatterplot relating a significant inverse linear correla-
tion between the vasomotor response to acetylcholine and the
intimal thickening severity (r = –0.60, P = .006).
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the paradoxical vasomotor response to acetylcholine was
more intensive the more severe the intimal thickness. In
addition, in the multivariate analysis endothelial dysfunc-
tion emerged as an independent predictor variable of inti-
mal thickening. These observations support an important
role of endothelial dysfunction in the development of allo-
graft vasculopathy. Using acetylcholine infusions to study
the endothelial function, Davis and colleagues19 observed
that coronary artery segments with early functional abnor-
malities had more intimal thickening by 1 year after trans-
plantation than those with a normal endothelial function.
However, using different methods, Julius and colleagues20
found no correlation between intimal thickening and
vasodilatation induced by the exercise, which, when it is
impaired, suggests endothelial dysfunction. The reasons for
these discrepant findings are not clear. However, in addition
to the differences in the methods, a likely explanation is the
episodic nature of the immunologic injury and the
reversibility of the endothelial dysfunction.19,24 Thus it has
been reported that the endothelial function can normalize,
even with the presence of intimal thickening.15 As seen in
previous series,25 no relationship was found between the
endothelium-independent vasodilator nitroglycerin and the
variables studied (eg, degree of intimal thickness and time
elapsed after the operation).
Several studies have shown those nonimmunologic fac-
tors, such as hypertriglyceridemia and pretransplant or post-
transplant hypercholesterolemia may contribute to the
development of allograft vascular disease.15,26-28 In the pres-
ent study, using multivariate regression analysis, we found
that the ischemic time is an independent predictor of intimal
thickening. In accordance with our observation, experimen-
tal models have demonstrated that a prolonged ischemic
time provokes vascular damage that contributes to the
development of chronic rejection in the allograft.29 In a
clinical study endothelial damage has been evidenced in
distant donors with long ischemic times and may worsen
after reperfusion.30 It has been observed that peritransplant
ischemic injury may increase the risk of development of
accelerated arteriosclerosis by 2.6 times.31
Weight gain leading to obesity is a common feature in
heart transplant recipients and has been identified as a pre-
dictor of intimal thickening severity.26,28 In our patient pop-
ulation we observed a significant relationship between
weight gain and the presence of endothelial dysfunction.
Although this association has been described in patients
with insulin-resistance syndrome linked with obesity who
have not undergone transplantation,32 to our knowledge, it
has not been reported in heart transplant recipients. This
suggests that the endothelial dysfunction associated with
obesity may be an early manifestation of allograft vascu-
lopathy. The modification of this cardiovascular risk factor
by means of a hypocaloric diet and controlled exercise
could improve the endothelial function and may prevent or
delay the development of the allograft vasculopathy.
In accordance with other studies,4,33 we observed that all
patients more than 1 year after the transplant operation had
some degree of intimal thickening, as determined with
IVUS. The disease initiates as early as 2 months after trans-
plant, and the most rapid rate of progression occurs during
the first year after heart transplant. It then follows a slow pro-
gression over time involving all the coronary segments.4,15,34
Using univariate analysis, Mehra and colleagues35 observed
that the time elapsed from transplantation was longer in
patients with severe intimal thickening than in those who
showed minimal-to-moderate intimal thickening (3.3 ± 1.4
vs 1.8 ± 1.2 years, P < .01). Using correlation and multi-
variate analysis, we observed that intimal thickening is
more severe the longer the time elapsed since heart trans-
plantation, this being an independent predictor of intimal
thickness severity.
The pathogenic mechanisms of cardiac allograft vascu-
lopathy are poorly understood, but the hypothesis of the
arteriosclerosis process postulated for the coronary artery
disease in patients who have not undergone transplantation
can be inferred to understand the accelerated arteriosclero-
sis disease in the cardiac allograft.36,37 According to this
model, the endothelial injury caused by allograft rejection,
peritransplant ischemia, and the traditional cardiovascular
risk factors triggers a cascade of events that initiate allograft
vasculopathy. These include reduction in the release of
endothelium-derived relaxing factors, as an increase in
platelet aggregation, and activation and adhesion of neu-
trophils to the lumen surface. The secretion of cytokines
and growth factors is thus stimulated, promoting mononu-
clear infiltration and smooth muscle cell migration to the
TABLE 2. Multiple regression analysis showing independent variables associated with intimal thickening
Unstandardized coefficients Standard error Standardized coefficients t P value
Constant 31.23 10.45 — 2.98 .01
Magnitude of vasomotor response, % –0.59 0.09 –0.88 –6.35 .0005
Years elapsed after transplant 2.66 0.96 0.34 2.75 .01
Ischemic time (min) 0.13 0.56 0.34 2.42 .03
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intima, as well as cellular proliferation with extracellular
matrix accumulation. In obese patients it has also been sug-
gested that the adipose cells may modulate the endothelium
participating in this process by the secretion of cytokines.38
The worsening of the allograft vasculopathy observed over
time is explained by endothelial injury caused by the sus-
tained chronic rejection. Other cardiovascular risk factors
may contribute further to the development of accelerated
arteriosclerosis in patients undergoing heart transplantation.
The present study has some limitations that should be
emphasized. First, our population represents a selected group
of patients with angiographically normal coronary arteries.
For safety reasons, IVUS was not performed in patients with
angiographic evidence of allograft disease, small diameter of
the LAD artery, or severe arterial tortuosity. Although compli-
cations during IVUS are rare,39 temporal occlusion of the ves-
sel during IVUS pullback and severe coronary spasm caused
by the rigidity of the catheter were the major concerns. In spite
of this, a vasospasm with ST-segment elevation occurred in 2
patients, reverting with intracoronary nitroglycerin. We per-
formed acetylcholine infusions in the LAD artery beyond the
origin of the first diagonal branch to avoid a potential exten-
sive vasoconstriction of the left coronary tree and to have a
reference point to perform reproducible measurements in the
same coronary segment in the group studied. However, this
method has the disadvantage that the vessel diameter is too
small to safely introduce an ultrasound catheter, especially
when there is stenotic (focal or diffuse) allograft vasculopathy.
Second, we evaluated the endothelial function and intimal
thickening in only one coronary segment. However, because
allograft vasculopathy is generally a diffuse disease, the other
coronary segments likely have a similar response. Finally,
although the data were collected prospectively, the design of
the study is cross-sectional. The effects of the cumulative risk
of other factors (eg, cholesterol and triglycerides) that may
contribute to the intimal thickness are not therefore evaluated. 
In conclusion, cardiac vascular allograft disease is a mul-
tifactorial entity, the severity of which increases over time.
The observations from this prospective study suggest that
endothelial dysfunction is a predictive factor of intimal
thickening development. Reduction of endothelial injury by
shortening the perioperative ischemic time and promoting
weight loss may prevent or delay the development of car-
diac allograft vasculopathy.
We thank Mrs Angeles Mañas for her assistance in the catheter-
ization laboratory.
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